What is Valliscor?
Established in 2012, Valliscor operates at the intersection of advanced material science and industrial manufacturing. The company specializes in the production of high-value fluorine-based compounds, such as bromofluoromethane and hexafluoro-1,3-butadiene, which serve as essential building blocks for modern technology. By maintaining rigorous ISO 9001 standards across its Corvallis and Albany facilities, Valliscor has positioned itself as a reliable partner for global supply chains requiring high-purity chemical intermediates. Their technical expertise in fluorine chemistry allows them to address complex crosslinking and material challenges, providing a competitive edge in the specialty chemicals market.
How much funding has Valliscor raised?
Valliscor has raised a total of $650K across 2 funding rounds:
Debt
$150K
Private Equity
$500K
Debt (2020): $150K with participation from PPP
Private Equity (2025): $500K, investors not publicly disclosed
Key Investors in Valliscor
Undisclosed Investor
A private equity firm focused on scaling industrial manufacturing and specialty chemical enterprises.
PPP
Public-Private Partnership
What's next for Valliscor?
With this major enterprise-level funding, Valliscor is poised to accelerate its industrial scaling efforts and enhance its research and development pipeline. The strategic allocation of this capital will likely focus on expanding manufacturing capacity at the Albany campus to meet the surging demand for semiconductor-grade materials. As the company transitions into this next phase of growth, it is expected to deepen its integration within the pharmaceutical and polymer sectors, leveraging its specialized chemical portfolio to capture additional market share. The firm remains focused on maintaining its commitment to safety and quality while scaling its production infrastructure to support long-term commercial objectives.
See full Valliscor company page
